EUVIMEDEUVIMED entdecken
Open Access

KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats

Michael Ippolito iD, Sean A Hayduk, William Kinney, Douglas E Brenneman, Sara Jane Ward

The Journal of Pharmacology and Experimental Therapeutics · 2024

DOI: 10.1124/jpet.124.002190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Michael Ippolito und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neural Sciences, Center for Substance Abuse Research, Temple University, Philadelphia, Pennsylvania (M.I., S.A.H., S.J.W.) and Pennsylv…. Hauptthemen laut MEDLINE: Cannabidiol, Rats, Sprague-Dawley, Peripheral Nervous System Diseases, Paclitaxel. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolRats, Sprague-DawleyPeripheral Nervous System DiseasesPaclitaxelAntineoplastic AgentsAnimalsRatsMaleReceptors, CannabinoidHyperalgesiaNeuralgiaOxaliplatinReceptors, G-Protein-CoupledCannabinoid Receptor AntagonistsDose-Response Relationship, Drug

Substanzen

CannabidiolPaclitaxelAntineoplastic AgentsReceptors, CannabinoidOxaliplatinGPR55 protein, ratReceptors, G-Protein-CoupledCannabinoid Receptor Antagonists

Autor:innen und Institutionen

  • Department of Neural Sciences, Center for Substance Abuse Research, Temple University, Philadelphia, Pennsylvania (M.I., S.A.H., S.J.W.) and Pennsylvania Biotechnology Center, Kannalife Sciences Inc, Doylestown Pennsylv…

ORCID-Profile: Michael Ippolito

Förderung

  • NIDA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Ippolito, M., Hayduk, S. A., Kinney, W., Brenneman, D. E., & Ward, S. J. (2024). KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.124.002190

Vancouver

Ippolito M, Hayduk SA, Kinney W, Brenneman DE, Ward SJ. KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.124.002190

BibTeX
@article{Ippolito2024,
  author = {Ippolito, Michael and Hayduk, Sean A and Kinney, William and Brenneman, Douglas E and Ward, Sara Jane},
  title = {KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  doi = {10.1124/jpet.124.002190}
}
Kostenlos starten →